Literature DB >> 8491062

Crossover studies: a modified analysis with more power.

T J Cleophas1.   

Abstract

Mesh:

Year:  1993        PMID: 8491062     DOI: 10.1038/clpt.1993.64

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  8 in total

1.  Early human screening of medications to treat drug addiction: novel paradigms and the relevance of pharmacogenetics.

Authors:  K A Perkins; C Lerman
Journal:  Clin Pharmacol Ther       Date:  2011-01-26       Impact factor: 6.875

2.  Initial Cross-Over Test of A Positive Allosteric Modulator of Alpha-7 Nicotinic Receptors to Aid Cessation in Smokers With Or Without Schizophrenia.

Authors:  Kenneth A Perkins; K N Roy Chengappa; Joshua L Karelitz; Margaret C Boldry; Valerie Michael; Taylor Herb; Jessica Gannon; Jaspreet Brar; Lisa Ford; Stefanie Rassnick; Darlene H Brunzell
Journal:  Neuropsychopharmacology       Date:  2017-11-29       Impact factor: 7.853

3.  Initial Evaluation of Fenofibrate for Efficacy in Aiding Smoking Abstinence.

Authors:  Kenneth A Perkins; Joshua L Karelitz; Valerie C Michael; Margaret Fromuth; Cynthia A Conklin; K N Roy Chengappa; Chris Hope; Caryn Lerman
Journal:  Nicotine Tob Res       Date:  2015-04-20       Impact factor: 4.244

4.  Ciprofloxacin absorption is impaired in patients given enteral feedings orally and via gastrostomy and jejunostomy tubes.

Authors:  D P Healy; M C Brodbeck; C E Clendening
Journal:  Antimicrob Agents Chemother       Date:  1996-01       Impact factor: 5.191

5.  Effects of nicotine versus placebo e-cigarette use on symptom relief during initial tobacco abstinence.

Authors:  Kenneth A Perkins; Joshua L Karelitz; Valerie C Michael
Journal:  Exp Clin Psychopharmacol       Date:  2017-06-26       Impact factor: 3.157

Review 6.  An efficient early phase 2 procedure to screen medications for efficacy in smoking cessation.

Authors:  Kenneth A Perkins; Caryn Lerman
Journal:  Psychopharmacology (Berl)       Date:  2013-12-03       Impact factor: 4.530

7.  Sensitivity and specificity of a procedure for early human screening of novel smoking cessation medications.

Authors:  Kenneth A Perkins; Caryn Lerman; Joshua L Karelitz; Nancy C Jao; K N Roy Chengappa; Garrett M Sparks
Journal:  Addiction       Date:  2013-07-12       Impact factor: 6.526

Review 8.  Paediatric labelling requirements. Implications for pharmacokinetic studies.

Authors:  J T Wilson; G L Kearns; D Murphy; S J Yaffe
Journal:  Clin Pharmacokinet       Date:  1994-04       Impact factor: 6.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.